MED Stock Overview
MEDICLIN Aktiengesellschaft operates hospitals in Germany.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 3/6 |
Past Performance | 1/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
MEDICLIN Aktiengesellschaft Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €3.00 |
52 Week High | €3.82 |
52 Week Low | €2.90 |
Beta | 0.13 |
1 Month Change | 0% |
3 Month Change | -7.98% |
1 Year Change | -15.25% |
3 Year Change | -22.68% |
5 Year Change | -51.61% |
Change since IPO | -72.85% |
Recent News & Updates
Shareholder Returns
MED | DE Healthcare | DE Market | |
---|---|---|---|
7D | 0% | 2.3% | 1.4% |
1Y | -15.3% | -19.3% | -7.2% |
Return vs Industry: MED exceeded the German Healthcare industry which returned -20.3% over the past year.
Return vs Market: MED underperformed the German Market which returned -7.9% over the past year.
Price Volatility
MED volatility | |
---|---|
MED Average Weekly Movement | 3.6% |
Healthcare Industry Average Movement | 4.3% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 10.1% |
10% least volatile stocks in DE Market | 2.7% |
Stable Share Price: MED is less volatile than 75% of German stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: MED's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 7,061 | Joachim Ramming | https://www.mediclin.de |
MEDICLIN Aktiengesellschaft operates hospitals in Germany. The company operates through Post-Acute, Acute, and Other Activities segments. It offers medical services in the areas of neurology, psychosomatics, orthopedics, internal medicine, cardiology, oncology, geriatrics, psychiatry, surgery, nursing care, and others.
MEDICLIN Aktiengesellschaft Fundamentals Summary
MED fundamental statistics | |
---|---|
Market Cap | €142.50m |
Earnings (TTM) | €7.03m |
Revenue (TTM) | €723.14m |
20.3x
P/E Ratio0.2x
P/S RatioIs MED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MED income statement (TTM) | |
---|---|
Revenue | €723.14m |
Cost of Revenue | €594.86m |
Gross Profit | €128.28m |
Other Expenses | €121.25m |
Earnings | €7.03m |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
Jul 31, 2023
Earnings per share (EPS) | 0.15 |
Gross Margin | 17.74% |
Net Profit Margin | 0.97% |
Debt/Equity Ratio | 46.7% |
How did MED perform over the long term?
See historical performance and comparison